Patents by Inventor Jesse A. May

Jesse A. May has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Serotonergic 5ht2 agonists for treating glaucoma
    Patent number: 6664286
    Abstract: Compounds with 5HT2 receptor agonist activity useful for treating glaucoma, including lowering intraocular pressure. Compositions and methods for their use are also disclosed.
    Type: Grant
    Filed: March 15, 2001
    Date of Patent: December 16, 2003
    Assignee: Alcon Manufacturing, Ltd.
    Inventors: Jesse A. May, Thomas R. Dean, Najam A. Sharif, Mark R. Hellberg
  • Serotonergic 5HT2 agonists for treating glaucoma
    Publication number: 20030203912
    Abstract: Compounds with 5HT2 receptor agonist activity useful for treating glaucoma, including lowering intraocular pressure. Compositions and methods for their use are also disclosed.
    Type: Application
    Filed: May 9, 2003
    Publication date: October 30, 2003
    Inventors: Jesse A. May, Thomas R. Dean, Najam A. Sharif, Mark R. Hellberg
  • Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
    Publication number: 20030181503
    Abstract: Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.
    Type: Application
    Filed: May 28, 2003
    Publication date: September 25, 2003
    Inventors: Jesse A. May, Paul W. Zinke
  • Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
    Publication number: 20030181504
    Abstract: Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.
    Type: Application
    Filed: May 28, 2003
    Publication date: September 25, 2003
    Inventors: Jesse A. May, Paul W. Zinke
  • Pyranoindazoles and their use for the treatment of glaucoma
    Publication number: 20030171418
    Abstract: Pyranoindazoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.
    Type: Application
    Filed: December 11, 2002
    Publication date: September 11, 2003
    Inventors: Hwang-Hsing Chen, Jesse A. May, Bryon S. Severns
  • Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles and their use for the treatment of glaucoma
    Publication number: 20030083346
    Abstract: Hydroxy substituted fused naphthyl-azoles and fused indeno-azoles are disclosed. Also disclosed are methods for the lowering and controlling of normal or elevated intraocular pressure as well as a method for the treatment of glaucoma using compositions containing one or more of the compounds of the present invention.
    Type: Application
    Filed: August 30, 2002
    Publication date: May 1, 2003
    Inventors: Jesse A. May, Paul W. Zinke
  • Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
    Publication number: 20020111381
    Abstract: Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
    Type: Application
    Filed: February 5, 2002
    Publication date: August 15, 2002
    Inventors: Thomas R. Dean, Jesse A. May, Verney L. Sallee, Louis Desantis
  • Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
    Patent number: 6344478
    Abstract: Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
    Type: Grant
    Filed: February 6, 2001
    Date of Patent: February 5, 2002
    Assignee: Alcon Manufacturing, Ltd.
    Inventors: Thomas R. Dean, Jesse A. May, Verney L. Sallee, Louis Desantis, Jr.
  • Use of cloprostenol and fluprostenol analogues to treat glaucoma and ocular hypertension
    Publication number: 20010023258
    Abstract: Disclosed is the use of cloprostenol and fluprostenol analogues in combination with carbonic anhydrase inhibitors for the treatment of glaucoma and ocular hypertension and ophthalmic compositions therefor.
    Type: Application
    Filed: February 6, 2001
    Publication date: September 20, 2001
    Inventors: Thomas R. Dean, Jesse A. May, Verney L. Sallee, Louis Desantis
  • Heterocyclic sulfonamides
    Patent number: 5681834
    Abstract: Compounds of the following structure are disclosed: ##STR1## Wherein G, J and the two atoms of the thiophene ring to which they are attached are the group ##STR2##
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: October 28, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Jesse A. May, Hwang-Hsing Chen, Anura Dantanarayana, Abdelmoula Namil
  • Ethacrynic acid-like compounds and use thereof to treat glaucoma
    Patent number: 5650541
    Abstract: Compounds structurally related to ethacrynic acid are described. The compounds are useful for controlling intraocular pressure. Unlike ethacrynic acid, the compounds of the present invention are capable of effectively penetrating the cornea. Methods of controlling intraocular pressure via topical application of one or more of the compounds to the eye and topical ophthalmic compositions useful in the treatment of glaucoma are also described.
    Type: Grant
    Filed: January 11, 1996
    Date of Patent: July 22, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventor: Jesse A. May
  • Thiophene sulfonamides useful as carbonic anhydrase inhibitors
    Patent number: 5646142
    Abstract: New thiophene sulfonamides useful as carbonic anhydrase inhibitors are disclosed. Methods for using the compounds to control IOP are also disclosed.
    Type: Grant
    Filed: July 8, 1994
    Date of Patent: July 8, 1997
    Assignee: Alcon Laboratories, Inc.
    Inventors: Anura P. Dantanarayana, Thomas R. Dean, Jesse A. May
  • Sulfonamides useful as carbonic anhydrase inhibitors
    Patent number: 5585377
    Abstract: Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
    Type: Grant
    Filed: December 23, 1994
    Date of Patent: December 17, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Thomas R. Dean, Jesse A. May, Hwang-Hsing Chen
  • Carbonic anhydrase inhibitors
    Patent number: 5538966
    Abstract: Compounds of the following formula are disclosed:Compounds of Formula I are the topic of this invention: ##STR1## Wherein G, J and the two atoms of the thiophene ring to which they are attached form a six-membered ring chosen from ##STR2## The compounds are useful as carbonic anhydrase inhibitors.
    Type: Grant
    Filed: January 20, 1995
    Date of Patent: July 23, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventors: Jesse A. May, Hwang-Hsing Chen, Brian DuPr e, Thomas R. Dean
  • Ethacrynic acid-like compounds and use thereof to treat glaucoma
    Patent number: 5506226
    Abstract: Compounds structurally related to ethacrynic acid are described. The compounds are useful for controlling intraocular pressure. Unlike ethacrynic acid, the compounds of the present invention are capable of effectively penetrating the cornea. Methods of controlling intraocular pressure via topical application of one or more of the compounds to the eye and topical ophthalmic compositions useful in the treatment of glaucoma are also described.
    Type: Grant
    Filed: April 19, 1993
    Date of Patent: April 9, 1996
    Assignee: Alcon Laboratories, Inc.
    Inventor: Jesse A. May
  • Sulfonamides useful as carbonic anhydrase inhibitors
    Patent number: 5378703
    Abstract: Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
    Type: Grant
    Filed: February 18, 1993
    Date of Patent: January 3, 1995
    Assignee: Alcon Laboratories, Inc.
    Inventors: Thomas R. Dean, Hwang-Hsing Chen, Jesse A. May
  • Sulfonamides useful as carbonic anhydrase inhibitors
    Patent number: 5240923
    Abstract: Sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
    Type: Grant
    Filed: October 9, 1991
    Date of Patent: August 31, 1993
    Assignee: Alcon Laboratories, Inc.
    Inventors: Thomas R. Dean, Hwang-Hsing Chen, Jesse A. May
  • Thiophene sulfonamides useful as carbonic anhydrase inhibitors
    Patent number: 5153192
    Abstract: Thiophene sulfonamides and pharmaceutical compositions containing the compounds useful in controlling intraocular pressure are disclosed. Methods for controlling intraocular pressure through administration of the compositions are also disclosed.
    Type: Grant
    Filed: November 27, 1990
    Date of Patent: October 6, 1992
    Assignee: Alcon Laboratories, Inc.
    Inventors: Thomas R. Dean, Hwang-Hsing Chen, Jesse A. May